Lupin LimitedNSE: LUPIN

Press Release Sep 13 2022

· Issued by Lupin Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-13-2022-3

Lupin Limited has informed the Exchange about press release dated 13-Sep-2022 titled Lupin Receives Health Canada Approval for Rymti�� (biosimilar Etanercept).

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases